Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,689 across all filing types
Latest filing 2023-10-24 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于2023年第三季度报告披露的提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (279 characters) indicating that the company's 2023 third quarter report has been disclosed on the official stock exchange website. It does not contain the actual financial data or detailed report content but rather directs investors to where the report can be found. This fits the pattern of a Report Publication Announcement (RPA) rather than the report itself (IR).
2023-10-24 Chinese
2023年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "迪瑞医疗科技股份有限公司2023 年第三季度报告" which translates to "Dirui Medical Technology Co., Ltd. 2023 Third Quarter Report." It contains detailed financial data including income statement, balance sheet, cash flow statement, and notes on financial performance for the third quarter of 2023. The document includes comprehensive financial metrics, explanations of changes in financial items, shareholder information, and other important disclosures typical of a quarterly financial report. It explicitly states it is a quarterly report and is unaudited. The length is substantial (15,000 characters), and it contains actual financial statements and analysis, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2023
2023-10-24 Chinese
关于公司获得医疗器械注册证暨医疗器械注册证变更的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt and changes of medical device registration certificates issued by regulatory authorities. It details specific product registration numbers, validity periods, and changes in product applicability and instructions. The content is regulatory in nature, informing shareholders and the public about compliance and product registration status, without containing financial data, management discussion, or detailed financial results. The document length is short (1436 characters) and it is an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-10-24 Chinese
第五届监事会第十次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Dirui Medical Technology Co., Ltd. regarding the approval of the company's 2023 third quarter report. It states that the Supervisory Board has reviewed and approved the Q3 report, confirming its compliance and accuracy. The document itself does not contain the full quarterly report or detailed financial data but rather announces the approval and directs readers to the full report on an external website. The document length is short (666 characters), and it serves as an official announcement of the approval of the interim report rather than the report itself. According to the 'Menu vs Meal' rule, this is a Regulatory Filing (RNS) because it is an announcement about the report, not the report itself.
2023-10-24 Chinese
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about receiving an invention patent certificate. It contains no financial data, no regulatory filings related to financial performance, no meeting materials, no voting results, no management or board changes, no earnings or capital updates. It is a specific announcement about intellectual property rights, which does not fit into any of the financial or corporate governance report categories. Given the content and length, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other categories.
2023-10-24 Chinese
第五届董事会第十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from Dirui Medical Technology Co., Ltd. It reports the approval of the 2023 third quarter report and a loan application. The document includes details about the meeting date, attendance, and voting results. It does not contain the actual financial statements or detailed financial data of the quarterly report but refers readers to the full report on an external website. The document is primarily an announcement of board decisions and approvals, not the report itself. Therefore, it fits best under Board/Management Information (MANG) as it announces board resolutions and management decisions.
2023-10-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.